Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

3(60.0%)

Phase 3

1(20.0%)

Phase 2

1(20.0%)

5Total

Phase 1(3)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT00193661Phase 2Completed

Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

Role: collaborator

NCT01931748Phase 3Completed

A Randomized, Double-Blind, Parallel, Non-Inferiority, Multicenter Trial Evaluate the Efficacy and Safety of UNCNT Compared to MELSMON in Female With Menopausal Syndrome

Role: lead

NCT01808300Phase 1Completed

Pharmacokinetic Drug Interaction Between Pregabalin and Thioctic Acid.

Role: lead

NCT00193700Phase 1Completed

Pharmacokinetic Evaluation of Testosterone Gel (1%)

Role: collaborator

NCT00002444Phase 1Completed

A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea

Role: lead

All 5 trials loaded